Contravisory Investment Management’s State Street Health Care Select Sector SPDR ETF XLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.1M Buy
6,914
+2,103
+44% +$313K 0.19% 99
2026
Q1
$705K Buy
4,811
+1,170
+32% +$180K 0.14% 119
2025
Q4
$564K Sell
3,641
-922
-20% -$138K 0.11% 134
2025
Q3
$635K Sell
4,563
-860
-16% -$116K 0.12% 124
2025
Q2
$731K Buy
5,423
+1,697
+46% +$229K 0.14% 99
2025
Q1
$544K Buy
3,726
+926
+33% +$135K 0.11% 127
2024
Q4
$385K Sell
2,800
-2,366
-46% -$346K 0.08% 176
2024
Q3
$796K Sell
5,166
-91
-2% -$13.8K 0.17% 82
2024
Q2
$766K Buy
5,257
+508
+11% +$72.9K 0.17% 76
2024
Q1
$702K Sell
4,749
-2,477
-34% -$355K 0.16% 87
2023
Q4
$985K Buy
7,226
+203
+3% +$26.4K 0.24% 53
2023
Q3
$904K Buy
7,023
+1,975
+39% +$262K 0.26% 49
2023
Q2
$670K Sell
5,048
-1,306
-21% -$172K 0.18% 67
2023
Q1
$823K Sell
6,354
-1,469
-19% -$192K 0.23% 51
2022
Q4
$1.06M Buy
7,823
+792
+11% +$105K 0.29% 45
2022
Q3
$852K Buy
7,031
+1,491
+27% +$192K 0.28% 45
2022
Q2
$710K Buy
5,540
+2,131
+63% +$279K 0.23% 49
2022
Q1
$467K Buy
3,409
+943
+38% +$125K 0.13% 98
2021
Q4
$347K Buy
2,466
+51
+2% +$6.77K 0.09% 160
2021
Q3
$307K Sell
2,415
-884
-27% -$117K 0.09% 157
2021
Q2
$416K Sell
3,299
-1,272
-28% -$156K 0.12% 105
2021
Q1
$534K Sell
4,571
-356
-7% -$41.1K 0.17% 66
2020
Q4
$559K Sell
4,927
-1,420
-22% -$155K 0.17% 60
2020
Q3
$669K Buy
6,347
+1,055
+20% +$111K 0.23% 49
2020
Q2
$530K Buy
5,292
+1,430
+37% +$141K 0.19% 58
2020
Q1
$342K Sell
3,862
-343
-8% -$33.3K 0.15% 66
2019
Q4
$428K Buy
4,205
+777
+23% +$74.7K 0.16% 71
2019
Q3
$309K Sell
3,428
-668
-16% -$61K 0.12% 111
2019
Q2
$379K Sell
4,096
-3,497
-46% -$314K 0.15% 80
2019
Q1
$697K Sell
7,593
-1,942
-20% -$175K 0.27% 47
2018
Q4
$825K Buy
9,535
+3,696
+63% +$335K 0.36% 47
2018
Q3
$556K Sell
5,839
-652
-10% -$58.9K 0.2% 54
2018
Q2
$542K Buy
6,491
+539
+9% +$44.7K 0.2% 61
2018
Q1
$484K Sell
5,952
-1,095
-16% -$93.3K 0.18% 55
2017
Q4
$583K Sell
7,047
-974
-12% -$80.3K 0.21% 52
2017
Q3
$656K Buy
+8,021
New +$644K 0.23% 49
2017
Q2
Sell
-1,813
Closed -$135K 273
2017
Q1
$135K Buy
1,813
+882
+95% +$64.3K 0.05% 140
2016
Q4
$64K Sell
931
-571
-38% -$39.6K 0.02% 115
2016
Q3
$108K Buy
1,502
+1,179
+365% +$86.8K 0.03% 89
2016
Q2
$23K Sell
323
-188
-37% -$13.2K 0.01% 112
2016
Q1
$35K Sell
511
-6,424
-93% -$430K 0.01% 100
2015
Q4
$500K Buy
6,935
+1,366
+25% +$96.5K 0.13% 47
2015
Q3
$369K Buy
5,569
+58
+1% +$4.24K 0.09% 43
2015
Q2
$410K Sell
5,511
-672
-11% -$49.8K 0.09% 44
2015
Q1
$448K Sell
6,183
-2,180
-26% -$155K 0.09% 43
2014
Q4
$572K Buy
8,363
+632
+8% +$42.3K 0.12% 40
2014
Q3
$494K Buy
7,731
+37
+0.5% +$2.32K 0.1% 41
2014
Q2
$468K Buy
7,694
+459
+6% +$27K 0.09% 46
2014
Q1
$423K Buy
7,235
+380
+6% +$21.9K 0.08% 49
2013
Q4
$380K Buy
+6,855
New +$367K 0.07% 51

Other funds holding XLV

Contravisory Investment Management's XLV Position: Q2 2026 in Review

Contravisory Investment Management increased its State Street Health Care Select Sector SPDR ETF (XLV) stake by 44% in Q2 2026, buying an estimated $313K and bringing the position to 6,914 shares worth $1.1M. The position accounts for 0.19% of the portfolio, ranked #99.

Contravisory Investment Management first reported a position in XLV in Q4 2013 and has held it in 50 quarters since. 1,852 funds tracked by Wall St. Rank hold XLV as of Q2 2026.

  • Contravisory Investment Management held 6,914 shares of State Street Health Care Select Sector SPDR ETF worth $1.1M as of Q2 2026.
  • Contravisory Investment Management bought 2,103 State Street Health Care Select Sector SPDR ETF shares in Q2 2026, an estimated $313K.
  • State Street Health Care Select Sector SPDR ETF made up 0.19% of Contravisory Investment Management's portfolio in Q2 2026, its #99 holding.
  • Contravisory Investment Management first reported a position in State Street Health Care Select Sector SPDR ETF in Q4 2013 and has held it in 50 quarters since.
  • 1,852 funds tracked by Wall St. Rank held State Street Health Care Select Sector SPDR ETF as of Q2 2026.

Based on Contravisory Investment Management's 13F filing for Q2 2026, filed 9 Jul 2026.